OPTIEMUSOptiemus Infracom Limited
IT · Electronics & Computer Distribution · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Optiemus Infracom Limited, together with its subsidiaries, trades in mobile handset and mobile accessories in India and internationally. It also manufactures telecommunication and allied products, including hearable and wearable, and IT hardware products, as well as drones and drone-based spectrum analyzers. The company was formerly known as Akanksha Cellular Limited and changed its name to Optiemus Infracom Limited in June 2011. Optiemus Infracom Limited was incorporated in 1993 and is based in Noida, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on OPTIEMUS — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 40/100)
- • Revenue growth: 7.9% YoY
- • Profit growth: -2.7% YoY
- • MACD: bearish
- • Price vs EMA21: below
Bull case
- • Debt/Equity: 0.45
- • Promoter holding: 72.8%
- • Price vs SMA50: above
- • Price vs SMA200: above
Bear case
- • Revenue growth: 7.9% YoY
- • Profit growth: -2.7% YoY
- • MACD: bearish
- • Price vs EMA21: below
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: 7.9% YoY
- • Profit growth: -2.7% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹50.09). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.